NEW YORK (Reuters Health) – Deferring percutaneous coronary intervention (PCI) and treating high-risk heart disease patients with optimal medical therapy alone does not increase the risk of death,…
NEW YORK (Reuters Health) – Treatment with the third generation bisphosphonate zoledronic acid (Zometa) may improve survival in lung cancer patients with bone metastases, Greek researchers report. Between…
NEW YORK (Reuters Health) – Elevated pre-operative blood levels of brain natriuretic peptide (BNP) or N-terminal-proBNP identify patients who are at increased risk for cardiovascular events within 30…
NEW YORK (Reuters Health) – Tamoxifen therapy has been linked to an increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE) and now new research suggests…
NEW YORK (Reuters Health) – When adverse events were compared between patients who received single versus multiple coronary stents, there were few complications overall and only a trend…
NEW YORK (Reuters Health) – Stress testing can be safely done in asymptomatic patients with severe aortic stenosis and is useful in predicting adverse cardiac events, including sudden…
NEW YORK (Reuters Health) – In patients with mild renal insufficiency, a single IV bolus of sodium bicarbonate can help prevent contrast-induced nephropathy (CIN) during percutaneous coronary intervention…
NEW YORK (Reuters Health) – The benefit of adding inhaled corticosteroids to long-acting beta-2 agonists for treating chronic obstructive pulmonary disease (COPD) is limited, and furthermore, it’s accompanied…
NEW YORK (Reuters Health) – In patients receiving first-line treatment for metastatic colon cancer, planned complete discontinuation of chemotherapy had a negative impact on duration of disease control…
Listen to a panel of three physicians who provide various perspectives on deep-vein thrombosis (DVT) prophylaxis from a clinical roundtable held on July 13, 2009 during the XXII…
